Large-scale production and purification of VLP-based vaccines

Journal of Invertebrate Pathology

Volumn 107, Issue SUPPL., 2011, Pages

  Vicente, Tiago ^a,b   Roldão, António ^a,b   Peixoto, Cristina ^a   Carrondo, Manuel J T ^a,c   Alves, Paula M ^a,b  

^a IBET   (Portugal)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Bioengineering challenges; Downstream processing; Modeling; Scalability; Upstream processing; VLP

Indexed keywords

VIRUS LIKE PARTICLE VACCINE;

ANIMAL; BACULOVIRUS; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INFLUENZA; METHODOLOGY; MOUSE; ORTHOMYXOVIRUS INFECTION; PHARMACEUTICS; QUALITY CONTROL; REVIEW; VIRION; VIROLOGY;

ANIMALS; BACULOVIRIDAE; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; INFLUENZA, HUMAN; MICE; ORTHOMYXOVIRIDAE INFECTIONS; QUALITY CONTROL; TECHNOLOGY, PHARMACEUTICAL; VACCINES, VIRUS-LIKE PARTICLE; VIRION;

HEXAPODA; MIRIDAE;

EID: 79960620240     PISSN: 00222011     EISSN: 10960805     Source Type: Journal    
DOI: 10.1016/j.jip.2011.05.004     Document Type: Review

References (53)

1. CBER guidelines, 2007. US Food and Drug Administration, Center for Biologics Evaluation and Research.
2. Almanza H., Cubillos C., Angulo I., Mateos F., Caston J.R., van der Poel W.H., Vinje J., Barcena J., Mena I. Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II. J. Clin. Microbiol. 2008, 46:3971-3979.
3. Bachmann A.S., Corpuz G., Hareld W.P., Wang G., Coller B.A. A simple method for the rapid purification of copia virus-like particles from Drosophila Schneider 2 cells. J. Virol. Methods 2004, 115:159-165.
4. Bernal V., Carinhas N., Yokomizo A.Y., Carrondo M.J., Alves P.M. Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism. Biotechnol. Bioeng. 2009, 104:162-180.
5. Betenbaugh M., Yu M., Kuehl K., White J., Pennock D., Spik K., Schmaljohn C. Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus. Virus Res. 1995, 38:111-124.
6. Buckland B.C. The process development challenge for a new vaccine. Nat. Med. 2005, 11:S16-S19.
7. Clinicaltrials.gov, 2010. http://clinicaltrials.gov.
8. Cook, J.C., 2001. Process for Purifying Human Papillomavirus Virus-Like Particles. US.
9. Cox M.M.J., Hashimoto Y. A fast track influenza virus vaccine produced in insect cells. J. Invertebr. Pathol. 2011, 107:S31.
10. Davis T.R., Wood H.A. Intrinsic glycosylation potentials of insect cell cultures and insect larvae. In Vitro Cell Dev. Biol. Anim. 1995, 31:659-663.
11. Deml L., Speth C., Dierich M.P., Wolf H., Wagner R. Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses. Mol. Immunol. 2005, 42:259-277.
12. French T.J., Marshall J.J., Roy P. Assembly of double-shelled, virus-like particles of bluetongue virus by the simultaneous expression of four structural proteins. J. Virol. 1990, 64:5695-5700.
13. Gotoh T., Miyazaki Y., Kikuchi K., Bentley W.E. Investigation of sequential behavior of carboxyl protease and cysteine protease activities in virus-infected Sf-9 insect cell culture by inhibition assay. Appl. Microbiol. Biotechnol. 2001, 56:742-749.
14. Grgacic E.V., Anderson D.A. Virus-like particles: passport to immune recognition. Methods 2006, 40:60-65.
15. Hang G.D., Chen C.J., Lin C.Y., Chen H.C., Chen H. Improvement of glycosylation in insect cells with mammalian glycosyltransferases. J. Biotechnol. 2003, 102:61-71.
16. Hervas-Stubbs S., Rueda P., Lopez L., Leclerc C. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J. Immunol. 2007, 178:2361-2369.
17. Jiang B., Barniak V., Smith R.P., Sharma R., Corsaro B., Hu B., Madore H.P. Synthesis of rotavirus-like particles in insect cells: comparative and quantitative analysis. Biotechnol. Bioeng. 1998, 60:369-374.
18. Jiang X., Wang M., Graham D.Y., Estes M.K. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 1992, 66:6527-6532.
19. Kalbfuss B., Wolff M., Geisler L., Tappe A., Wickramasinghe R., Thom V., Reichl U. Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers. J. Membr. Sci. 2007, 299:251-260.
20. Krammer F., Schinko T., Palmberger D., Tauer C., Messner P., Grabherr R. Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. Mol. Biotechnol. 2010, 45:226-234.
21. Lechmann M., Murata K., Satoi J., Vergalla J., Baumert T.F., Liang T.J. Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice. Hepatology 2001, 34:417-423.
22. Maranga L., Rueda P., Antonis A.F., Vela C., Langeveld J.P., Casal J.I., Carrondo M.J. Large scale production and downstream processing of a recombinant porcine parvovirus vaccine. Appl. Microbiol. Biotechnol. 2002, 59:45-50.
23. Mellado M.C., Mena J.A., Lopes A., Ramirez O.T., Carrondo M.J., Palomares L.A., Alves P.M. Impact of physicochemical parameters on in vitro assembly and disassembly kinetics of recombinant triple-layered rotavirus-like particles. Biotechnol. Bioeng. 2009, 104:674-686.
24. Mollerup J.M., Hansen T.B., Kidal S., Staby A. Quality by design - thermodynamic modelling of chromatographic separation of proteins. J. Chromatogr. A. 2008, 1177:200-206.
25. Morenweiser R. Downstream processing of viral vectors and vaccines. Gene. Ther. 2005, 12:S103-S110.
26. Mortola E., Roy P. Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Lett. 2004, 576:174-178.
27. O'Reilly D.R., Miller L.K., Verne A.L. Baculovirus Expression Vectors: A Laboratory Manual 1994, Freeman, New York.
28. Ozturk, S.S., Hu, W.-S. (Eds.), 2006. Cell Culture Technology for Pharmaceutical and Cell-based Therapies. New York.
29. Paavonen J., Jenkins D., Bosch F.X., Naud P., Salmeron J., Wheeler C.M., Chow S.N., Apter D.L., Kitchener H.C., Castellsague X., de Carvalho N.S., Skinner S.R., Harper D.M., Hedrick J.A., Jaisamrarn U., Limson G.A., Dionne M., Quint W., Spiessens B., Peeters P., Struyf F., Wieting S.L., Lehtinen M.O., Dubin G. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007, 369:2161-2170.
30. Peixoto C., Sousa M.F.Q., Silva A.C., Carrondo M.J.T., Alves P.M. Downstream processing of triple layered rotavirus like particles. J. Biotechnol. 2007, 127:452-461.
31. Pillay S., Meyers A., Williamson A.L., Rybicki E.P. Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system. Biotechnol. Prog. 2009, 25:1153-1160.
32. Prashad M., Tarrach K. Depth filtration: cell clarification of bioreactor offloads. Filtr. Sep. 2006, 43:28-30.
33. Pumpens P., Grens E. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 2001, 44:98-114.
34. Robinson, J., 2009. An Alternative to the Scale-up and Distribution of Pandemic Influenza Vaccine. Biopharm International. Jan 2.
35. Roldão A., Carrondo M.J.T., Alves P.M., Oliveira R. Stochastic simulation of protein expression in the baculovirus/insect cells system. Comput. Chem. Eng. 2008, 32:68-77.
36. Roldão A., Mellado M.C., Castilho L.R., Carrondo M.J., Alves P.M. Virus-like particles in vaccine development. Expert Rev. Vaccines 2010, 9:1149-1176.
37. Roldao A., Vieira H.L., Charpilienne A., Poncet D., Roy P., Carrondo M.J., Alves P.M., Oliveira R. Modeling rotavirus-like particles production in a baculovirus expression vector system: infection kinetics, baculovirus DNA replication, mRNA synthesis and protein production. J. Biotechnol. 2007, 128:875-894.
38. Rueda P., Fominaya J., Langeveld J.P., Bruschke C., Vela C., Casal J.I. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. Vaccine 2000, 19:726-734.
39. Saha K., Lin Y.C., Wong P.K. A simple method for obtaining highly viable virus from culture supernatant. J. Virol. Methods 1994, 46:349-352.
40. Shrestha M.P., Scott R.M., Joshi D.M., Mammen M.P., Thapa G.B., Thapa N., Myint K.S., Fourneau M., Kuschner R.A., Shrestha S.K., David M.P., Seriwatana J., Vaughn D.W., Safary A., Endy T.P., Innis B.L. Safety and efficacy of a recombinant hepatitis E vaccine. New Engl. J. Med. 2007, 356:895-903.
41. Sun Y., Carrion R., Ye L., Wen Z., Ro Y.T., Brasky K., Ticer A.E., Schwegler E.E., Patterson J.L., Compans R.W., Yang C. Protection against lethal challenge by Ebola virus-like particles produced in insect cells. Virology 2009, 383:12-21.
42. Tatman J.D., Preston V.G., Nicholson P., Elliott R.M., Rixon F.J. Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses. J. Gen. Virol. 1994, 75(Pt 5):1101-1113.
43. Teixeira A.P., Carinhas N., Dias J.M., Cruz P., Alves P.M., Carrondo M.J., Oliveira R. Hybrid semi-parametric mathematical systems: bridging the gap between systems biology and process engineering. J. Biotechnol. 2007, 132:418-425.
44. Teixeira A.P., Oliveira R., Alves P.M., Carrondo M.J. Advances in on-line monitoring and control of mammalian cell cultures: supporting the PAT initiative. Biotechnol. Adv. 2009, 27:726-732.
45. Trilisky E.I., Koku H., Czymmek K.J., Lenhoff A.M. Relation of structure to performance characteristics of monolithic and perfusive stationary phases. J. Chromatogr. A. 2009, 1216:6365-6376.
46. Vedvick, T.S., Steadman, B., Richardson, C., Foubert, T.R., Petrie, C.R., 2008. Virus-Like Particle Purification. US.
47. Vicente T., Mota J.P., Peixoto C., Alves P.M., Carrondo M.J. Analysis of adsorption of a baculovirus bioreaction bulk on an ion-exchange surface by surface plasmon resonance. J. Biotechnol. 2010, 148:171-181.
48. Vicente T., Peixoto C., Alves P.M., Carrondo M.J. Modeling electrostatic interactions of baculovirus vectors for ion-exchange process development. J. Chromatogr. A 2010, 1217:3754-3764.
49. Vicente T., Sousa M.F.Q., Peixoto C., Mota J.P.B., Alves P.M., Carrondo M.J.T. Anion-exchange membrane chromatography for purification of rotavirus-like particles. J. Membrane Sci. 2008, 311:270-283.
50. Vieira H.L.A., Estevao C., Roldao A., Peixoto C.C., Sousa M.F.Q., Cruz P.E., Carrondo M.J.T., Alves P.M. Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production. J. Biotechnol. 2005, 120:72-82.
51. Wolff M.W., Siewert C., Hansen S.P., Faber R., Reichl U. Purification of cell culture-derived modified vaccinia Ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography. Biotechnol. Bioeng. 2010, 107:312-320.
52. Wu C., Soh K.Y., Wang S. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum. Gene. Ther. 2007, 18:665-672.
53. Wu C.Y., Yeh Y.C., Yang Y.C., Chou C., Liu M.T., Wu H.S., Chan J.T., Hsiao P.W. Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus. PLoS ONE 2010, 5:e9784.